Intellipharmaceutics International Inc.
IPCIQ
$0.00
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -538.24% | 93.56% | 59.63% | 55.28% | 76.59% |
| Total Depreciation and Amortization | -21.17% | -21.36% | -21.17% | 2.82% | -21.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -975.00% | -- |
| Total Other Non-Cash Items | 942.86% | 96.40% | 115.62% | -25.21% | -100.75% |
| Change in Net Operating Assets | 4,501.69% | -87.02% | -15.36% | -86.12% | 86.48% |
| Cash from Operations | 182.16% | 126.49% | 97.47% | 41.66% | 78.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 182.16% | -44.42% | 97.47% | 101.22% | 78.49% |